Clinical Trials Directory

Trials / Unknown

UnknownNCT03724266

Effect of Using Nanochitosan Versus Calcium Hydroxide as Disinfectant on Pain and Apical Bone Healing

Effect of Using Nanochitosan Versus Calcium Hydroxide as Intracanal Medications on the Postoperative Pain and Apical Bone Healing

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Effect of Using Nanochitosan versus Calcium Hydroxide as Intracanal Medications on the Postoperative Pain and Apical Bone Healing

Detailed description

PICO approach P (population): maxillary anterior teeth having necrotic pulp with symptomatic apical periodontitis with evidence of apical radiolucency (minimum size 2 mm x 2 mm). I (intervention):0.2% nanochitosan as intracanal medication. C (control): calcium hydroxide paste intracanal medication. O (outcome): Primary outcome: postoperative pain at time interval 4, 12, 24, 48, 72 hours Secondary outcome: 1. Postoperative pain, swelling, palpation, percussion and mobility at one week, 3, 6, 12 months 2. Number of analgesic tablets used at 4, 12, 24, 48, 72 hours and one week. 3. healing of apical periodontitis using CBCT at 3, 6, 12 months

Conditions

Interventions

TypeNameDescription
DRUGChitosanchitosan will be used as intracanal medication
DRUGCalcium Hydroxideintracanal medication

Timeline

Start date
2018-10-01
Primary completion
2020-05-01
Completion
2020-12-01
First posted
2018-10-30
Last updated
2018-11-01

Source: ClinicalTrials.gov record NCT03724266. Inclusion in this directory is not an endorsement.